Stories

People lorem ipsum dolor sit amet

Donec auctor sed ipsum quis lobortis

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean vel nunc justo. Nullam mattis

4 min. read or listen
Published on 05/07/2022
Read More

Lorem ipsum dolor sit amet consectetur adipiscing

Ad erat habitant cum ac fusce sodales posuere urna nibh id, proin penatibus pulvinar pretium class

5 min. read or listen
Published on 03/07/2022
Read More

Suspendisse blandit molestie mauris lobortis

Vivamus semper dolor in aliquet varius. Duis ornare maximus nibh non suscipit. Vivamus diam quam,

4 min. read or listen
Published on 12/05/2022
Read More

Proin viverra hendrerit mi, vel tincidunt turpis

Nam blandit a lacus vitae pulvinar. Duis facilisis ligula sit amet tellus lobortis faucibus. Vivamus

4 min. read or listen
Published on 07/04/2022
Read More

You might also enjoy our news

New models for non-melanoma skin cancer

Almirall and the Centre for Genomic Regulation (CRG) collaborate to develop and characterize novel preclinical models for non-melanoma skin cancer

Almirall joins IMI project FACILITATE

We participate in FACILITATE, a patient-driven Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants.

AlmirallShare 7th call is out now!

AlmirallShare new call is seeking new partenship opportunities for preclinical and clinical stage assets that can become new treatments for skin diseases

Subscribe to our latest news